Literature DB >> 10864967

Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting.

D D Song1, S N Haber.   

Abstract

Dopaminergic lesions result in the acute loss of striatal dopamine content, the loss of tyrosine hydroxylase-immunoreactive fibers, upregulation of preproenkephalin mRNA expression, and compensatory changes in the synthesis and metabolism of dopamine. Despite the severe loss of fine tyrosine hydroxylase-immunoreactive fibers, larger fibers persist. We found that some tyrosine hydroxylase fiber types increase their branching and become thicker after partial lesion. To determine whether the remaining tyrosine hydroxylase fibers were degenerative or part of a compensatory response, we morphologically characterized striatal tyrosine hydroxylase fibers and compared them to silver-stained degenerative structures. Branched and large tyrosine hydroxylase fiber types were nondegenerative. Furthermore, normal preproenkephalin mRNA expression was maintained despite severe overall loss of tyrosine hydroxylase fibers in striatal regions with abundant branching, whereas preproenkephalin mRNA expression increased in severely depleted regions that lacked branched fibers, indicating that branching or sprouting was involved in the compensation for dopamine depletion and the maintenance of normal preproenkephalin expression. In support of compensatory sprouting by tyrosine hydroxylase fibers, mRNA for growth associated protein-43 was upregulated in dopaminergic midbrain cells. We conclude that an important compensatory response to partial dopaminergic depletion is the formation of new branches or sprouting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864967      PMCID: PMC6772281     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  80 in total

1.  Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo.

Authors:  F Gonon
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Distribution of GAP-43 mRNA in the brain stem of adult rats as evidenced by in situ hybridization: localization within monoaminergic neurons.

Authors:  C Bendotti; A Servadio; R Samanin
Journal:  J Neurosci       Date:  1991-03       Impact factor: 6.167

3.  Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo.

Authors:  K Chergui; M F Suaud-Chagny; F Gonon
Journal:  Neuroscience       Date:  1994-10       Impact factor: 3.590

4.  Regulation of striatal enkephalin turnover in rats receiving antagonists of specific dopamine receptor subtypes.

Authors:  I Mocchetti; J R Naranjo; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1987-06       Impact factor: 4.030

5.  The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons.

Authors:  J R Hollerman; A A Grace
Journal:  Brain Res       Date:  1990-11-19       Impact factor: 3.252

6.  Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease.

Authors:  M Varastet; D Riche; M Maziere; P Hantraye
Journal:  Neuroscience       Date:  1994-11       Impact factor: 3.590

7.  Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA.

Authors:  M Comb; P H Seeburg; J Adelman; L Eiden; E Herbert
Journal:  Nature       Date:  1982-02-25       Impact factor: 49.962

8.  Preproenkephalin mRNA and methionine-enkephalin increase in mouse striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.

Authors:  K P Gudehithlu; A M Duchemin; G A Tejwani; N H Neff; M Hadjiconstantinou
Journal:  J Neurochem       Date:  1991-03       Impact factor: 5.372

9.  Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions.

Authors:  J D Elsworth; A Y Deutch; D E Redmond; J R Taylor; J R Sladek; R H Roth
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

10.  Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system.

Authors:  T E Robinson; Z Mocsary; D M Camp; I Q Whishaw
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

View more
  47 in total

1.  The nigrostriatal pathway in the rat: A single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments.

Authors:  L Prensa; A Parent
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

2.  Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson's disease.

Authors:  Alicia M Pickrell; Milena Pinto; Aline Hida; Carlos T Moraes
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

3.  Neural correlates underlying micrographia in Parkinson's disease.

Authors:  Tao Wu; Jiarong Zhang; Mark Hallett; Tao Feng; Yanan Hou; Piu Chan
Journal:  Brain       Date:  2015-11-02       Impact factor: 13.501

4.  Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.

Authors:  R Pattarini; R J Smeyne; J I Morgan
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

5.  Lateralization of brain activity pattern during unilateral movement in Parkinson's disease.

Authors:  Tao Wu; Yanan Hou; Mark Hallett; Jiarong Zhang; Piu Chan
Journal:  Hum Brain Mapp       Date:  2015-01-19       Impact factor: 5.038

6.  Differential effects of environment-induced changes in body temperature on modafinil's actions against methamphetamine-induced striatal toxicity in mice.

Authors:  Mariana Raineri; Betina González; Celeste Rivero-Echeto; Javier A Muñiz; María Laura Gutiérrez; Carolina I Ghanem; Jean Lud Cadet; Edgar García-Rill; Francisco J Urbano; Veronica Bisagno
Journal:  Neurotox Res       Date:  2014-09-27       Impact factor: 3.911

7.  MPTP Induces Systemic Parkinsonism in Middle-Aged Cynomolgus Monkeys: Clinical Evolution and Outcomes.

Authors:  Feng Yue; Sien Zeng; Rongping Tang; Guoxian Tao; Piu Chan
Journal:  Neurosci Bull       Date:  2016-10-03       Impact factor: 5.203

8.  Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment.

Authors:  Xiomara A Perez; Kathryn T O'Leary; Neeraja Parameswaran; J Michael McIntosh; Maryka Quik
Journal:  Mol Pharmacol       Date:  2009-01-14       Impact factor: 4.436

Review 9.  Abuse of amphetamines and structural abnormalities in the brain.

Authors:  Steven Berman; Joseph O'Neill; Scott Fears; George Bartzokis; Edythe D London
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Kyota Fujita; Toshihiro Seike; Noriko Yutsudo; Mizuki Ohno; Hidetaka Yamada; Hiroo Yamaguchi; Kunihiko Sakumi; Yukiko Yamakawa; Mizuho A Kido; Atsushi Takaki; Toshihiko Katafuchi; Yoshinori Tanaka; Yusaku Nakabeppu; Mami Noda
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.